
Please try another search
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. Its lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation. The company is also developing bexmarilimab for the treatment of hematological and solid tumor cancers; and in combination with care therapies, azacitidine, and other hypomethylating agents in relapsed/refractory myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. In addition, it develops receptors involved in regulation of immune response in organ damage and bone marrow regeneration. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.
Name | Age | Since | Title |
---|---|---|---|
Tuomo Patsi | 60 | 2023 | Independent Non-Executive Chairman |
Juho Markku Jalkanen | 46 | 2017 | Founder, CEO & Director |
Markku Tapani Jalkanen | 70 | 2006 | Non- Executive Director |
Huaizheng Peng | 62 | 2015 | Board Observer |
John Poulos | 70 | 2017 | Independent Non-Executive Director |
Naval G. Daver | - | 2024 | Member of the Scientific Advisory Board |
Toni K. Choueiri | - | 2024 | Member of the Scientific Advisory Board |
Tom Powles | - | 2024 | Member of the Scientific Advisory Board |
Christophe Massard | - | 2019 | Member of the Scientific Advisory Board |
Christine Ann Roth | 61 | 2023 | Independent Non-Executive Director |
Amer Zeidan | - | 2024 | Member of the Scientific Advisory Board |
Mika Kontro | - | 2024 | Member of the Scientific Advisory Board |
Marie-Louise Helena Fjallskog | 61 | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review